Baxa Corporation Launches Call For Research Papers
Main Category: Nursing / MidwiferyAlso Included In: Public Health
Article Date: 31 Mar 2008 - 2:00 PDT
Baxa Corporation announces a call for research papers involving its new PadLock® Set Saver product. The PadLock device is designed to promote best practice for aseptic IV administration set storage; preventing contamination of the administration set when disconnected from the patient. The recently released product provides temporary storage of the IV administration line between drug administrations, replacing the need for single-use, sterile caps. Baxa is offering several unrestricted grants for research studies on the usage and benefits of its new product. Grants will be awarded for research intended for presentation at the INS, AVA, APIC or similar meetings and/or publication in the Journal of Infusion Nursing, Journal of Vascular Access, American Journal of Infection Control or similar publications.
"We are interested in objective research studies on areas of interest to healthcare providers, such as cost-benefit studies, aseptic techniques and best practices," says Megan Kleckner, Product Manager of the announcement. "Research studies regarding compliance with best practice and the reduction of infection risks are also key targets." Professionals interested in pursuing the grants should submit contact information and research ideas via email to email protected from spam bots. Submissions will be reviewed and applicants responded to by Baxa Corporation in a timely manner.
Baxa Corporation is a world leader in developing innovative technology for the safe handling, packaging and administration of fluid medications in hospital and alternate-care settings. Renowned for enhancing patient safety and improving processes within pharmacy settings, with the PadLock Set Saver, Baxa brings its expertise and experience to the patient bedside.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock® Set Saver, Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide.
Baxa Corporation
Visit our nursing / midwifery section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/102187.php>
APA
http://www.medicalnewstoday.com/releases/102187.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
essays writing
posted by poter on 6 Jan 2011 at 12:50 pmwriters believe that writing a research paper is much like the task of a sculptor who takes a massive block of stone and chisels it into a work of art.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



